Table 1.
Immunohistochemical Analysis of IL-27 Expression in HL
Case no. | Diagnosis | Site | LMP1 status | % of EBI3+ HRS cells | % of p28+ HRS cells |
---|---|---|---|---|---|
1 | NS | Lymph node | pos | ++++ | − |
2 | NS | Lymph node | pos | ++++ | + |
3 | NS | Lymph node | neg | ++++ | − |
4 | NS | Lymph node | neg | ++++ | + |
5 | NS | Lymph node | neg | ++++ | + |
6 | NS | Mediastinum | neg | ++++ | − |
7 | NS | Mediastinum | neg | ++++ | − |
8 | LD | Lymph node | pos | ++++ | + |
9 | LD | Lymph node | neg | ++++ | − |
10 | MC | Lymph node | pos | ++++ | − |
11 | MC | Lymph node | pos | ++++ | + |
12 | uc | Lymph node | pos | ++++ | − |
13 | NLP | Lymph node | neg | ++++ | − |
14 | NLP | Lymph node | neg | ++++ | − |
NS, nodular sclerosis; LD, lymphocyte depletion; MC, mixed cellularity; uc, unclassified; NLP, nodular lymphocyte predominant.
, virtually all cells negative;
, 1 to 5% positive cells;
, >90% positive cells.